HR1124: HR1124 Blood Plasma Donation Awareness Day in Georgia; February 17, 2026; recognize
2025-2026 Regular Session · Introduced version · Last action January 28, 2026
26 LC 65 0032
House Resolution 1124
By: Representatives Kahaian of the 81st, Stinson of the 150th, Martinez of the 111th, Reeves
of the 99th, Griffin of the 149th, and others
A RESOLUTION
Recognizing February 17, 2026, as Blood Plasma Donation Awareness Day in Georgia; and1
for other purposes.2
WHEREAS, the lives of millions of individuals are heavily reliant on life-saving therapies3
derived from human blood plasma, emphasizing the need for a rob ust and inclusive blood4
plasma collection infrastructure; and5
WHEREAS, the United States is home to a vast network of United States Food and Drug6
Administration licensed blood plasma donation centers, which collectively facilitated over7
493 million plasma donations from 2007 to 2021, underscoring the critical role these centers8
play in supporting healthcare in this country; and9
WHEREAS, approximately 33 million liters of blood plasma are meticulously fractionated10
each year, yielding essential therapeutic plasma proteins vital for a wide range of medical11
treatments, including emergencies related to uncontrollable bleeding, autoimmune disorders,12
sickle cell disease, and various chronic conditions; and13
WHEREAS, the demand for therapies derived from blood plasma has surged dramatically14
over the past two decades, driven by advancements in diagnosing rare diseases, elevated15
H. R. 1124
- 1 -
26 LC 65 0032
standards of patient care, and enhanced patient access to innov ative treatments, further16
highlighting the need for increased representation in blood plasma collection efforts; and17
WHEREAS, plasma-derived medicinal products (PDMPs) are indispen sable in managing18
urgent health crises tied to bleeding, autoimmune conditions, sickle cell disease, and chronic19
health issues, and play crucial roles in treating patients with rare and life-threatening20
illnesses, such as primary immunodeficiencies and hemophilia; and21
WHEREAS, millions of donations are made annually at blood plasm a collection centers22
throughout the United States, revealing the essential contribution these local collection sites23
make within the healthcare framework of this country and state and the pressing need for24
more diverse representation in the industry; and25
WHEREAS, the global blood plasma market has achieved remarkable financial growth,26
reaching approximately $30 billion in 2022, a significant increase from just over $5 billion27
in 2000, highlighting the enormous economic potential embedded within the plasma industry;28
and29
WHEREAS, sickle cell disease is a chronic, incurable genetic bl ood disease that30
disproportionately affects individuals of African descent, with approximately 100,000 people31
in the United States and over 11,000 people in this state living with the condition; and32
WHEREAS, sickle cell disease is most prevalent among individuals of African descent, with33
approximately 90 percent of those affected identifying as such, emphasizing the significant34
impact of this disease on communities of color; and35
H. R. 1124
- 2 -
26 LC 65 0032
WHEREAS, therapeutic plasma exchange has been recognized as a p otentially useful36
treatment in resolving complications of sickle cell disease, including acute chest syndrome37
and hepatic crisis, highlighting the critical need for accessib le and inclusive blood plasma38
collection infrastructure; and39
WHEREAS, Dr. Charles Richard Drew, an African American pioneering figure in modern40
blood banking and twentieth-century medicine, revolutionized blood plasma donation and41
storage processes, fundamentally shaping the field as it is known today, and his legacy serves42
as a powerful reminder of the importance of integration and rep resentation in the medical43
field; and44
WHEREAS, despite the significant contributions of individuals o f African descent who45
comprise over 86 percent of blood plasma donations nation wide, there are currently no46
plasma collection centers owned by individuals from this demographic in this state, a glaring47
disparity that underscores the need for awareness to promote a more representative blood48
plasma industry that reflects the communities it serves.49
NOW, THEREFORE, BE IT RESOLVED BY THE HOUSE OF REPRESENTATIVES that50
the members of this body recognize February 17, 2026, as Blood Plasma Donation51
Awareness Day in Georgia.52
BE IT FURTHER RESOLVED that the Clerk of the House of Representatives is authorized53
and directed to make appropriate copies of this resolution avai lable for distribution to the54
public and the press.55
H. R. 1124
- 3 -